æ±äº¬å€§åŠã¯4æ3æ¥ãéåã«ããèè³ªä»£è¬æ¹åã«é¢ããæ°ããªååæ©æ§ãæããã«ãããšçºè¡šããã
ææã¯ãæ±å€§å€§åŠé¢ 蟲åŠçåœç§åŠç ç©¶ç§ã®äœè€éäžéææãã®ç ç©¶ããŒã ã«ãããã®ãç ç©¶ã®è©³çްãªå 容ã¯ã3æ18æ¥ä»ãã§ãAmerican Journal of Physiology Endocrinology and Metabolismãã«æ²èŒãããã
ã¡ã¿ããªãã¯ã·ã³ãããŒã ã®çºçã«ã¯ã圱é¿ãšããŠéåç¿æ £ã®æç¡ã倧ãããç¹ã«éåã«ããèè³ªä»£è¬æ¹åã«ãããŠã¯ãéªšæ Œçã§ããªãã¿ã³ãã¯è³ªãªããŒãŒ(LPL:Lipoprotein lipase)ãçºçŸãäžæããããšãéèŠã ãšããããLPLã¯éåã«ããçºçŸäžæããåŸã«è¡äžã«åæ³ãããããããã¯ãã³ãããVLDLããªã©ã®ãªãã¿ã³ãã¯è³ªäžã«å«ãŸãããããªã°ãªã»ãªãããåè§£ããã®åŸãåè§£ç£ç©ã§ããèèªé žãéªšæ Œç现èãç©æ¥µçã«åã蟌ãããšã§è質代è¬ãæ¹åããä»çµã¿ã ããããéååŸã®éªšæ Œçã§ãªãLPLçºçŸãäžæããã®ããååã¬ãã«ã§æç¢ºã«ã¯ããã£ãŠããªãã£ãã
ããããäžãè¿å¹Žãéåã«ããä»£è¬æ¹åå¹æãæ ãå åãšããŠããšãã«ã®ãŒã»ã³ãµã¿ã³ãã¯è³ª(AMPK:AMP-activated protein kinase)ããæ³šç®ãããŠãããAMPKã¯éåã«ãã£ãŠçãã现èå ãšãã«ã®ãŒæ¯æžãæç¥ãããã®å埩ã«åªããæ©èœååã ãä»åã®ç ç©¶ã§ã¯ãAMPKãæ žå å容äœãPPAR(peroxisome proliferator-activated receptor)γ1ãã®çºçŸäº¢é²ãä»ããŠLPLã®çºçŸäžæãèªå°ããããšãæ°ãã«èŠåºãããããã«AMPKã«ããPPARγ1ã®çºçŸäº¢é²ã®äžéšã¯ãmRNAã®å®å®åãšããäžé¢šå€ãã£ãæ©æ§ã«ãã調ç¯ãããŠããããšãæããã«ããã(ç»å1ã»2)ã
ä»åã®ç ç©¶ã§ã¯ãæåºŠ10°ã®ãã¬ãããã«ãçšããããŠã¹ã«å¯ŸããŠæ¯å15mã®é床ã§30åã®èµ°è¡éåãé±5åã4é±éã«ãããè² è·ããããããããã®çµæãééå矀ã®ããŠã¹ã«æ¯ã¹ãéå矀ããŠã¹ã§ã¯éªšæ Œçã«ãããPPARγ1ããã³LPLã®ã¡ãã»ã³ãžã£ãŒRNA(mRNA)éãææã«äžæããããšãèªãããããšããã
æ žå å容äœã§ããPPARãã¡ããªãŒã¯Î±ãβ/ÎŽãγã®3çš®é¡ã®ãµãã¿ã€ããååšããããŸããŸãªãšãã«ã®ãŒä»£è¬ã«é¢ããããšãç¥ãããŠãããéªšæ Œçã«ãããŠã¯PPARãã¡ããªãŒäžã®PPARαãããã³PPARβ/ÎŽãèèªé žä»£è¬é¢é£éºäŒåã®çºçŸã調ç¯ããæ©èœãæã€ãäžæ¹ãPPARγã¯èèªçްèã«ãããŠéèŠãªåããããŠããããéªšæ Œçã«ãããçºçŸéã¯èèªçµç¹ã®10%以äžã§ããããšããããã®æ©èœã«ã€ããŠã¯äžæãªç¹ãå€ãæ®ãããŠããã
ããã§ç现èã«ãããPPARγ1ã®æ©èœãæããã«ãããããå¹é€ç管现èãC2C12ãã«PPARγ1ãéå°çºçŸãããçš®ã ã®éºäŒåçºçŸå¿çã®è¿œè·¡ã宿œãããã®ã§ããããã®çµæãLPL mRNAããã³ã¿ã³ãã¯è³ªã®çªåºããäžæã確èªãããããšãããPPARγ1ãLPLçºçŸã調ç¯ããå åã§ããããšãæããã«ãªã£ãã
ããã«ç ç©¶ããŒã ã¯ãéåæã«PPARγ1çºçŸãäžæãããäžæµå åã®åå®ã詊ã¿ãããšã«ããããã§çç®ããå åãéåã«ããæŽ»æ§åããAMPKãšããããã ãC2C12ãAMPK掻æ§åå€ã§ãããAICARãããã¡ããã©ã«ãã³ããAMPKã鿥çã«æŽ»æ§åãããH2O2ããå«ãå¹å°ã§å¹é€ãããšãPPARγ1mRNAãªãã³ã«ã¿ã³ãã¯è³ªã®äžæã確èªãããããã®äžæã¯ãåæã«AMPKé»å®³å€ãå¹å°ã«å ãããšè§£é€ãããããšãããAMPK掻æ§åã«ããPPARγ1mRNAãäžæããããšãæããã«ãªã£ãã®ã§ããã
ããã«ããŠã¹ã«å¯ŸããŠ3æ¥éã«ãããAICARã®æäžãè¡ããããšããããã¯ãéªšæ Œçã«ãããŠPPARγ1ãLPL mRNAã®ææãªäžæã確èªãããã以äžã®çµæãããéåâAMPK掻æ§åâPPARγ1å¢å âLPLäžæã®ååæ©æ§ãæããã«ãããã®ã§ãããéååºæ¿ã«ããéªšæ Œçã¯LPLåæ³ãäžæããããšãã«ã®ãŒæºãšãªãéé¢èèªé žã现èå ã«ç©æ¥µçã«åã蟌ãé©å¿ãããŠãããšèããããšãã§ãããšããã
ç¶ããŠãAMPK掻æ§åã«ããPPARγ1çºçŸäžæã®ååæ©æ§ã®è§£æãè¡ãããããã®çµæãšããŠè峿·±ãããšã«ãPPARγ1mRNAã¯éåžžããã4æéã®åæžæã§åè§£ããã®ã«å¯ŸããAMPKãæŽ»æ§åããããšã§åæžæã12æéçšåºŠãŸã§å»¶äŒžããããšã倿ãããã§èŠãããmRNAå®å®åã¯ãAMPKé»å®³å€ã«ããæå¶ããã圢ã ãPPARγ1mRNAã®ã3'é翻蚳é åãã«ã¯ãåæžæã®çãmRNAã«ç¹åŸŽçãªãAU-riché åãã5ã«æååšãããããããããããŠã¹ãã©ããã§ä¿åãããŠããããã®çµæã¯ãAMPKãAU-riché åãä»ããmRNAã®åè§£æ©æ§ãæå¶ããäœçšãæã€ããšã瀺åããŠãããšããã
ä»åã®ææã«ãããéªšæ Œçã«ããããéåâAMPK掻æ§åâPPARγ1å¢å âLPLäžæã®ååæ©æ§ãæãããšãªã£ããAMPKã¯ãéåã®ã¿ãªããé£åã«å«ãŸããçš®ã ã®ããªãã§ããŒã«ãªã©ã«ãã£ãŠã掻æ§åãããããšãç¥ãããŠãããæ¥ãã¹ãé«éœ¢ç€ŸäŒã«ãããŠãéåãååã«ã§ããªãé«éœ¢è ã®å¥åº·ç¶æã«ãAMPK掻æ§åèœãæã€é£åãæŽ»çšãããããšãæåŸ ããããšããã